In a report released today, Anthony Vendetti from Maxim Group maintained a Sell rating on National Beverage (FIZZ), with a price target of $45. The company’s shares closed yesterday at $68.27, close to its 52-week low of $65.68.
Vendetti wrote:
“Yesterday after the market close, FIZZ reported F3Q19 (Jan) revenue and EBITDA below both our estimates and consensus. LaCroix all-channel sales have been flat-to-down since October, which we believe is due primarily to public scrutiny of its ingredients. We view the $2.90 per share special dividend paid on 1/29/19 as a sub-optimal use of capital, given the opportunity cost of not investing in LaCroix.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 5.8% and a 50.6% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Ellex Medical Lasers Limited, Restoration Robotics Inc, and Sensus Healthcare Inc.
National Beverage has an analyst consensus of Moderate Sell, with a price target consensus of $80.
See today’s analyst top recommended stocks >>
The company has a one-year high of $123.27 and a one-year low of $65.68. Currently, National Beverage has an average volume of 316.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
National Beverage Corp. engages in the development, manufacture, market, and sale of flavored beverage products. Its brands include Shasta, Faygo, Everfresh, LaCroix, Rip It, Asante, Mt. Shasta, ClearFruit, Mr. Pure, Ritz, Crystal Bay, Cascadia Sparkling Clear, Cascadia Only 2 Calories, Ohana, Big Shot, and St. Nick’s.
